MRNA

Moderna, Inc.

MX Healthcare Biotechnology

Latest week
17 Jul 2026
Close
1100.000000
Fair value
1138.597179
Next-week expectancy
Undecided 52.28%
Sharemaestro

MRNA Chart Pack

Moderna, Inc.

Exchange
MEX
Latest week
17 Jul 2026
Close
1100.000000
Fair value
1138.597179
Next-week expectancy
Undecided 52.28%
Generated
21 Jul 2026 10:00
Sector
Healthcare
Industry
Biotechnology

Chart Summary

Over the latest 12 completed weeks ending 2026-07-17, MRNA rose 37.50%, moving from 800.01 to 1,100.00. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 51.32 and has improved across the 12-week window. Market Dynamics is 0.87 on the latest week. Next-week expectancy is undecided at 52.28% based on similar historical setup states.

Key Points

Week Ending
17 Jul 2026
Latest Close
1,100.00
12-Week Change
37.50%
Trend Signal
Active
Next-Week Expectancy
Undecided 52.28%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Below
Relative Strength
51.32
Market Dynamics
0.87

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
17 Jul 2026
Latest Close
1,100.00
12-Week Change
37.50%
Trend Signal
Active
Next-Week Expectancy
Undecided 52.28%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Below
Relative Strength
51.32
Market Dynamics
0.87

Over the latest 12 completed weeks ending 2026-07-17, MRNA rose 37.50%, moving from 800.01 to 1,100.00. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 51.32 and has improved across the 12-week window. Market Dynamics is 0.87 on the latest week. Next-week expectancy is undecided at 52.28% based on similar historical setup states.

Industry Peers

Mexico equities in Biotechnology

Stock Exchange Week Open High Low Close Change
ARDX Ardelyx, Inc. MEX 17 Jul 2026 99.00 99.00 99.00 99.00 0.00%
BMRN BioMarin Pharmaceutical Inc. MEX 17 Jul 2026 959.00 959.00 959.00 959.00 0.00%
BNTXN BioNTech SE MEX 17 Jul 2026 1590.00 1590.00 1590.00 1590.00 0.00%
DNA Ginkgo Bioworks Holdings, Inc. MEX 17 Jul 2026 170.00 170.00 170.00 170.00 0.00%
INCY Incyte Corporation MEX 17 Jul 2026 2067.00 2067.00 2067.00 2067.00 0.00%
KYNB Kyntra Bio, Inc. MEX 17 Jul 2026 127.90 127.90 127.90 127.90 0.00%
REGN Regeneron Pharmaceuticals, Inc. MEX 17 Jul 2026 10835.99 10835.99 10835.99 10835.99 0.00%
SMMT Summit Therapeutics Inc. MEX 17 Jul 2026 290.12 290.12 290.12 290.12 0.00%
SRPT SAREPTA THERAPEUTICS INC MEX 17 Jul 2026 294.00 294.00 294.00 294.00 0.00%
VRTX Vertex Pharmaceuticals Incorporated MEX 17 Jul 2026 8474.00 8474.00 8295.00 8319.00 -1.83%
CRSPN CRISPR Therapeutics AG MEX 17 Jul 2026 880.00 880.30 850.00 850.00 -3.41%
INO Inovio Pharmaceuticals, Inc. MEX 17 Jul 2026 21.26 21.26 20.00 20.00 -5.93%
ALT1 Altimmune, Inc. MEX 17 Jul 2026 53.40 53.40 50.09 50.09 -6.20%
PROK ProKidney Corp. MEX 17 Jul 2026 29.50 29.50 27.50 27.59 -6.47%
OCGN Ocugen, Inc. MEX 17 Jul 2026 26.00 26.00 23.88 23.88 -8.15%
NVAX Novavax, Inc. MEX 17 Jul 2026 156.50 156.50 142.50 142.63 -8.86%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.